This set the stage for an application for a Medline entry. After an unsuccessful first attempt, we implemented systematically and meticulously those items the committee felt were missing, while correcting those criticised during this review process. Specifically, we invited prominent international opinion leaders to become members of the editorial board, made conflict of interest statements mandatory, implemented a vigorous peer-review system now supported by an electronic platform (Editorial Manager: www.cardiovascmed.ch -online submission), removed advertisements from the front page and focused our efforts on increasing the number of original research articles. The change of name to "Cardiovascular Medicine" was only the last step in this process. Fortunately, this apparently obvious name was still available for our use. "Cardiovascular Medicine" is also a programme, indicating that in the years to come we shall be publishing more articles in English, a language not considered quintessentially Swiss but today understood and mastered effectively by most of us. Indeed, the majority of Swiss, whether we like it or not, are today more competent in English than in any other of our country's second languages, particularly on medical issues. Thus, it seems appropriate to change the name of our official journal accordingly and to make this a programme for the future. Since this initiative was approved by the president of our society, Christian Seiler, along with those of our sister societies, we are happy to announce that we shall put this programme into practice in the current issue of our journal. Let us now keep our fingers crossed for the success of our next attempt to enter the Pubmed system. The editors of the journal are convinced that as "Cardiovascular Medicine" we shall sail into a successful future, confident that we can count on the support of our members, editorial board members, authors and reviewers.
